Search research articles
Contact Us
Filters
Showing results (351-360 of 476) with videos related to
Page
of 48
Sort By:
BMC Genomics
|
June 5, 2019
Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series
A C Picornell, I Echavarria, E Alvarez, et al.
Nature Communications
|
January 3, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers
Diego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Breast Cancer Research : BCR
|
April 22, 2006
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay
Laurent Perreard, Cheng Fan, John F Quackenbush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Supervised risk predictor of breast cancer based on intrinsic subtypes
Joel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Cancer Research
|
March 26, 2026
Integrated Multi-omic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer
Ang Gao, Parth H Khatri, Gui Ma, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers
Diego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2021
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy
Tomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, et al.
Scientific Reports
|
July 11, 2024
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Natàlia Lorman-Carbó, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, et al.
Science Advances
|
April 26, 2017
A murine preclinical syngeneic transplantation model for breast cancer precision medicine
Lorenzo Federico, Zechen Chong, Dong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2023
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Page
of 48
Search research articles
Search
Showing results (351-360 of 476) with videos related to
Sort By:
Page
of 48
BMC Genomics
|
June 5, 2019
Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series
A C Picornell, I Echavarria, E Alvarez, et al.
Nature Communications
|
January 3, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers
Diego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Breast Cancer Research : BCR
|
April 22, 2006
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay
Laurent Perreard, Cheng Fan, John F Quackenbush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Supervised risk predictor of breast cancer based on intrinsic subtypes
Joel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Cancer Research
|
March 26, 2026
Integrated Multi-omic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer
Ang Gao, Parth H Khatri, Gui Ma, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers
Diego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2021
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy
Tomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, et al.
Scientific Reports
|
July 11, 2024
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Natàlia Lorman-Carbó, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, et al.
Science Advances
|
April 26, 2017
A murine preclinical syngeneic transplantation model for breast cancer precision medicine
Lorenzo Federico, Zechen Chong, Dong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2023
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Page
of 48